Densa Hospitals & Research Center Comprehensive Company Profile
Key Indicators
- Authorised Capital ₹ 2.00 M
as on 07-07-2024
- Paid Up Capital ₹ 1.78 M
as on 07-07-2024
- Company Age 34 Year, 6 Months
- Last Filing with ROC 31 Mar 2023
- Satisfied Charges ₹ 6.15 M
as on 07-07-2024
- Revenue 3.02%
(FY 2020)
- Profit 201.60%
(FY 2020)
- Ebitda 27.31%
(FY 2020)
- Net Worth 24.19%
(FY 2020)
- Total Assets 0.13%
(FY 2020)
About Densa Hospitals & Research Center
The Corporate was formerly known as Densa Pharmaceuticals Private Limited. The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 2.00 M and a paid-up capital of Rs 1.78 M.
The company has closed loans amounting to ₹6.15 M, and has no open charges as per Ministry of Corporate Affairs (MCA) records.
Devendra Singh and Parwati Singh serve as directors at the Company.
- CIN/LLPIN
U85100MH1990PTC055871
- Company No.
055871
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
19 Mar 1990
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Mumbai
Industry
Company Details
- Location
Thane, Maharashtra, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Densa Hospitals & Research Center?
Board Members(2)
Financial Performance and Corporate Structure Insights of Densa Hospitals & Research Center.
Densa Hospitals & Research Center Private Limited, for the financial year ended 2020, experienced modest growth in revenue, with a 3.02% increase. The company also saw a substantial improvement in profitability, with a 201.6% increase in profit. The company's net worth Soared by an impressive increase of 24.19%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations | |||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Densa Hospitals & Research Center?
In 2018, Densa Hospitals & Research Center had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
The Saraswat Co.Operative Bank Ltd. Creation Date: 12 Jun 1995 | ₹0.30 M | Satisfied |
The Saraswat Co-Operative Bank Ltd. Creation Date: 04 Feb 1994 | ₹1.00 M | Satisfied |
Maharashtra State Financial Corporation Creation Date: 31 Dec 1991 | ₹4.85 M | Satisfied |
How Many Employees Work at Densa Hospitals & Research Center?
Unlock and access historical data on people associated with Densa Hospitals & Research Center, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Densa Hospitals & Research Center, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Densa Hospitals & Research Center's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
